Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-09

FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc. under ANDA071524, approving a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trazodone hydrochloride (Trazodone hydrochloride)

Snippet

SUPPL AP for TRAZODONE HYDROCHLORIDE (TRAZODONE HYDROCHLORIDE)